Logo image of JUVE.MI

JUVENTUS FOOTBALL CLUB SPA (JUVE.MI) Stock Fundamental Analysis

BIT:JUVE - Euronext Milan - IT0005572778 - Common Stock - Currency: EUR

3.1915  -0.09 (-2.7%)

Fundamental Rating

1

JUVE gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 46 industry peers in the Entertainment industry. JUVE may be in some trouble as it scores bad on both profitability and health. JUVE has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

JUVE had negative earnings in the past year.
In the past year JUVE has reported a negative cash flow from operations.
In the past 5 years JUVE always reported negative net income.
JUVE had negative operating cash flow in 4 of the past 5 years.
JUVE.MI Yearly Net Income VS EBIT VS OCF VS FCFJUVE.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100M -200M -300M -400M

1.2 Ratios

Looking at the Return On Assets, with a value of -29.34%, JUVE is doing worse than 84.78% of the companies in the same industry.
JUVE's Return On Equity of -495.63% is on the low side compared to the rest of the industry. JUVE is outperformed by 73.91% of its industry peers.
Industry RankSector Rank
ROA -29.34%
ROE -495.63%
ROIC N/A
ROA(3y)-23.28%
ROA(5y)-20.49%
ROE(3y)-311.57%
ROE(5y)-718.42%
ROIC(3y)N/A
ROIC(5y)N/A
JUVE.MI Yearly ROA, ROE, ROICJUVE.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K -2.5K

1.3 Margins

With a decent Gross Margin value of 89.06%, JUVE is doing good in the industry, outperforming 73.91% of the companies in the same industry.
JUVE's Gross Margin has been stable in the last couple of years.
JUVE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 89.06%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.03%
GM growth 5Y-0.68%
JUVE.MI Yearly Profit, Operating, Gross MarginsJUVE.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

1

2. Health

2.1 Basic Checks

JUVE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for JUVE has been increased compared to 1 year ago.
Compared to 5 years ago, JUVE has less shares outstanding
The debt/assets ratio for JUVE has been reduced compared to a year ago.
JUVE.MI Yearly Shares OutstandingJUVE.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
JUVE.MI Yearly Total Debt VS Total AssetsJUVE.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

JUVE has an Altman-Z score of 0.09. This is a bad value and indicates that JUVE is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.09, JUVE is not doing good in the industry: 67.39% of the companies in the same industry are doing better.
JUVE has a Debt/Equity ratio of 6.68. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of JUVE (6.68) is worse than 69.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 6.68
Debt/FCF N/A
Altman-Z 0.09
ROIC/WACCN/A
WACC7.48%
JUVE.MI Yearly LT Debt VS Equity VS FCFJUVE.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

2.3 Liquidity

A Current Ratio of 0.44 indicates that JUVE may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.44, JUVE is doing worse than 80.43% of the companies in the same industry.
JUVE has a Quick Ratio of 0.44. This is a bad value and indicates that JUVE is not financially healthy enough and could expect problems in meeting its short term obligations.
JUVE has a worse Quick ratio (0.43) than 80.43% of its industry peers.
Industry RankSector Rank
Current Ratio 0.44
Quick Ratio 0.43
JUVE.MI Yearly Current Assets VS Current LiabilitesJUVE.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

3

3. Growth

3.1 Past

JUVE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -69.87%.
Looking at the last year, JUVE shows a very negative growth in Revenue. The Revenue has decreased by -19.28% in the last year.
JUVE shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.35% yearly.
EPS 1Y (TTM)-69.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-23.29%
Revenue 1Y (TTM)-19.28%
Revenue growth 3Y-8.21%
Revenue growth 5Y-4.35%
Sales Q2Q%-10.75%

3.2 Future

The Earnings Per Share is expected to grow by 25.85% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 9.00% on average over the next years. This is quite good.
EPS Next Y93.08%
EPS Next 2Y38.98%
EPS Next 3Y25.85%
EPS Next 5YN/A
Revenue Next Year38.95%
Revenue Next 2Y16.31%
Revenue Next 3Y11.13%
Revenue Next 5Y9%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
JUVE.MI Yearly Revenue VS EstimatesJUVE.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 200M 400M 600M
JUVE.MI Yearly EPS VS EstimatesJUVE.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 -0.2 -0.4 -0.6 -0.8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

JUVE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for JUVE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
JUVE.MI Price Earnings VS Forward Price EarningsJUVE.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60 -80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
JUVE.MI Per share dataJUVE.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5

4.3 Compensation for Growth

A more expensive valuation may be justified as JUVE's earnings are expected to grow with 25.85% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.98%
EPS Next 3Y25.85%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for JUVE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

JUVENTUS FOOTBALL CLUB SPA

BIT:JUVE (3/7/2025, 7:00:00 PM)

3.1915

-0.09 (-2.7%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)02-27 2025-02-27
Earnings (Next)N/A N/A
Inst Owners9.07%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.21B
Analysts43.64
Price Target2.43 (-23.86%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.62%
PT rev (3m)19.17%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)21.43%
EPS NY rev (3m)59.26%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)1.71%
Revenue NY rev (3m)7.49%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.26
P/FCF N/A
P/OCF N/A
P/B 30.1
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.71
EYN/A
EPS(NY)-0.04
Fwd EYN/A
FCF(TTM)-0.4
FCFYN/A
OCF(TTM)-0.12
OCFYN/A
SpS0.98
BVpS0.11
TBVpS-0.77
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -29.34%
ROE -495.63%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 89.06%
FCFM N/A
ROA(3y)-23.28%
ROA(5y)-20.49%
ROE(3y)-311.57%
ROE(5y)-718.42%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.03%
GM growth 5Y-0.68%
F-Score2
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 6.68
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 68.62%
Cap/Sales 28.13%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.44
Quick Ratio 0.43
Altman-Z 0.09
F-Score2
WACC7.48%
ROIC/WACCN/A
Cap/Depr(3y)94.78%
Cap/Depr(5y)102.09%
Cap/Sales(3y)38.62%
Cap/Sales(5y)46.16%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-69.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-23.29%
EPS Next Y93.08%
EPS Next 2Y38.98%
EPS Next 3Y25.85%
EPS Next 5YN/A
Revenue 1Y (TTM)-19.28%
Revenue growth 3Y-8.21%
Revenue growth 5Y-4.35%
Sales Q2Q%-10.75%
Revenue Next Year38.95%
Revenue Next 2Y16.31%
Revenue Next 3Y11.13%
Revenue Next 5Y9%
EBIT growth 1Y-46.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year173.21%
EBIT Next 3Y39.88%
EBIT Next 5Y24.33%
FCF growth 1Y25.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-8.98%
OCF growth 3YN/A
OCF growth 5YN/A